Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

Xin Li, Ryan A. Priest, William J. Woodward, Ian J. Tagge, Faisal Siddiqui, Wei Huang, William Rooney, Tomasz (Tom) Beer, Mark Garzotto, Charles Jr Springer

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The feasibility of shutter-speed model dynamic-contrast-enhanced MRI pharmacokinetic analyses for prostate cancer detection was investigated in a prebiopsy patient cohort. Differences of results from the fast-exchange-regime- allowed (FXR-a) shutter-speed model version and the fast-exchange-limit- constrained (FXL-c) standard model are demonstrated. Although the spatial information is more limited, postdynamic-contrast-enhanced MRI biopsy specimens were also examined. The MRI results were correlated with the biopsy pathology findings. Of all the model parameters, region-of-interest-averaged K trans difference [ΔKtrans ≡ K trans(FXR-a) - Ktrans(FXL-c)] or two-dimensional K trans(FXR-a) vs. kep(FXR-a) values were found to provide the most useful biomarkers for malignant/benign prostate tissue discrimination (at 100% sensitivity for a population of 13, the specificity is 88%) and disease burden determination. (The best specificity for the fast-exchange-limit- constrained analysis is 63%, with the two-dimensional plot.) Ktrans and kep are each measures of passive transcapillary contrast reagent transfer rate constants. Parameter value increases with shutter-speed model (relative to standard model) analysis are larger in malignant foci than in normal-appearing glandular tissue. Pathology analyses verify the shutter-speed model (FXR-a) promise for prostate cancer detection. Parametric mapping may further improve pharmacokinetic biomarker performance. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)171-178
Number of pages8
JournalMagnetic Resonance in Medicine
Volume69
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Prostatic Neoplasms
Pharmacokinetics
Biomarkers
Pathology
Biopsy
Prostate
Population

Keywords

  • DCE-MRI
  • prostate
  • shutter-speed

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection. / Li, Xin; Priest, Ryan A.; Woodward, William J.; Tagge, Ian J.; Siddiqui, Faisal; Huang, Wei; Rooney, William; Beer, Tomasz (Tom); Garzotto, Mark; Springer, Charles Jr.

In: Magnetic Resonance in Medicine, Vol. 69, No. 1, 01.2013, p. 171-178.

Research output: Contribution to journalArticle

@article{8b43a1ca16bd41f48eec3d88374ca625,
title = "Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection",
abstract = "The feasibility of shutter-speed model dynamic-contrast-enhanced MRI pharmacokinetic analyses for prostate cancer detection was investigated in a prebiopsy patient cohort. Differences of results from the fast-exchange-regime- allowed (FXR-a) shutter-speed model version and the fast-exchange-limit- constrained (FXL-c) standard model are demonstrated. Although the spatial information is more limited, postdynamic-contrast-enhanced MRI biopsy specimens were also examined. The MRI results were correlated with the biopsy pathology findings. Of all the model parameters, region-of-interest-averaged K trans difference [ΔKtrans ≡ K trans(FXR-a) - Ktrans(FXL-c)] or two-dimensional K trans(FXR-a) vs. kep(FXR-a) values were found to provide the most useful biomarkers for malignant/benign prostate tissue discrimination (at 100{\%} sensitivity for a population of 13, the specificity is 88{\%}) and disease burden determination. (The best specificity for the fast-exchange-limit- constrained analysis is 63{\%}, with the two-dimensional plot.) Ktrans and kep are each measures of passive transcapillary contrast reagent transfer rate constants. Parameter value increases with shutter-speed model (relative to standard model) analysis are larger in malignant foci than in normal-appearing glandular tissue. Pathology analyses verify the shutter-speed model (FXR-a) promise for prostate cancer detection. Parametric mapping may further improve pharmacokinetic biomarker performance. Magn Reson Med, 2013. {\circledC} 2012 Wiley Periodicals, Inc.",
keywords = "DCE-MRI, prostate, shutter-speed",
author = "Xin Li and Priest, {Ryan A.} and Woodward, {William J.} and Tagge, {Ian J.} and Faisal Siddiqui and Wei Huang and William Rooney and Beer, {Tomasz (Tom)} and Mark Garzotto and Springer, {Charles Jr}",
year = "2013",
month = "1",
doi = "10.1002/mrm.24211",
language = "English (US)",
volume = "69",
pages = "171--178",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

AU - Li, Xin

AU - Priest, Ryan A.

AU - Woodward, William J.

AU - Tagge, Ian J.

AU - Siddiqui, Faisal

AU - Huang, Wei

AU - Rooney, William

AU - Beer, Tomasz (Tom)

AU - Garzotto, Mark

AU - Springer, Charles Jr

PY - 2013/1

Y1 - 2013/1

N2 - The feasibility of shutter-speed model dynamic-contrast-enhanced MRI pharmacokinetic analyses for prostate cancer detection was investigated in a prebiopsy patient cohort. Differences of results from the fast-exchange-regime- allowed (FXR-a) shutter-speed model version and the fast-exchange-limit- constrained (FXL-c) standard model are demonstrated. Although the spatial information is more limited, postdynamic-contrast-enhanced MRI biopsy specimens were also examined. The MRI results were correlated with the biopsy pathology findings. Of all the model parameters, region-of-interest-averaged K trans difference [ΔKtrans ≡ K trans(FXR-a) - Ktrans(FXL-c)] or two-dimensional K trans(FXR-a) vs. kep(FXR-a) values were found to provide the most useful biomarkers for malignant/benign prostate tissue discrimination (at 100% sensitivity for a population of 13, the specificity is 88%) and disease burden determination. (The best specificity for the fast-exchange-limit- constrained analysis is 63%, with the two-dimensional plot.) Ktrans and kep are each measures of passive transcapillary contrast reagent transfer rate constants. Parameter value increases with shutter-speed model (relative to standard model) analysis are larger in malignant foci than in normal-appearing glandular tissue. Pathology analyses verify the shutter-speed model (FXR-a) promise for prostate cancer detection. Parametric mapping may further improve pharmacokinetic biomarker performance. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc.

AB - The feasibility of shutter-speed model dynamic-contrast-enhanced MRI pharmacokinetic analyses for prostate cancer detection was investigated in a prebiopsy patient cohort. Differences of results from the fast-exchange-regime- allowed (FXR-a) shutter-speed model version and the fast-exchange-limit- constrained (FXL-c) standard model are demonstrated. Although the spatial information is more limited, postdynamic-contrast-enhanced MRI biopsy specimens were also examined. The MRI results were correlated with the biopsy pathology findings. Of all the model parameters, region-of-interest-averaged K trans difference [ΔKtrans ≡ K trans(FXR-a) - Ktrans(FXL-c)] or two-dimensional K trans(FXR-a) vs. kep(FXR-a) values were found to provide the most useful biomarkers for malignant/benign prostate tissue discrimination (at 100% sensitivity for a population of 13, the specificity is 88%) and disease burden determination. (The best specificity for the fast-exchange-limit- constrained analysis is 63%, with the two-dimensional plot.) Ktrans and kep are each measures of passive transcapillary contrast reagent transfer rate constants. Parameter value increases with shutter-speed model (relative to standard model) analysis are larger in malignant foci than in normal-appearing glandular tissue. Pathology analyses verify the shutter-speed model (FXR-a) promise for prostate cancer detection. Parametric mapping may further improve pharmacokinetic biomarker performance. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc.

KW - DCE-MRI

KW - prostate

KW - shutter-speed

UR - http://www.scopus.com/inward/record.url?scp=84872864346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872864346&partnerID=8YFLogxK

U2 - 10.1002/mrm.24211

DO - 10.1002/mrm.24211

M3 - Article

VL - 69

SP - 171

EP - 178

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 1

ER -